{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:29:48Z","timestamp":1795008588684,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["439669440"],"award-info":[{"award-number":["439669440"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DKFZ Hector Cancer Institute","award":["UCGLORI"],"award-info":[{"award-number":["UCGLORI"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    N\n                    <jats:sup>6<\/jats:sup>\n                    -Methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) is the most abundant internal modification of eukaryotic mRNAs and regulates target transcripts throughout the mRNA life cycle. Although changes in m\n                    <jats:sup>6<\/jats:sup>\n                    A have been reported in human cancers, technical limitations have hindered a comprehensive understanding of the cancer-associated m\n                    <jats:sup>6<\/jats:sup>\n                    A landscape. Here, we use GLORI-sequencing to establish the first transcriptome-wide, single-nucleotide resolution maps of m\n                    <jats:sup>6<\/jats:sup>\n                    A in bladder cancer. Comparing bladder cancer and healthy bladder samples, we discover two key m\n                    <jats:sup>6<\/jats:sup>\n                    A signatures: a global dilution of methylation and a focal hypermethylation at 3\u2032-UTRs. The global methylation dilution results from an increased expression of unmethylated transcripts and a decreased expression of methylated transcripts. In contrast, focal 3\u2019-UTR hypermethylation is associated with the overexpression of VIRMA, a component of the m\n                    <jats:sup>6<\/jats:sup>\n                    A writer complex. A functional role of VIRMA is confirmed in knockdown experiments that reveal reduced 3\u2019-UTR methylation and oncogenic phenotypes of bladder cancer cells. Our study is the first to describe the m\n                    <jats:sup>6<\/jats:sup>\n                    A epitranscriptomic landscape of cancer at single-base resolution and provides first insights into the processes that generate its characteristic signatures.\n                  <\/jats:p>","DOI":"10.1038\/s44319-026-00739-y","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:43:09Z","timestamp":1774276989000},"page":"2118-2143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The bladder cancer m6A landscape is defined by global methylation dilution and focal 3\u2032-UTR hypermethylation"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2080-6293","authenticated-orcid":false,"given":"Jonas","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7714-0763","authenticated-orcid":false,"given":"Jinyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-3375","authenticated-orcid":false,"given":"Felix","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-7667","authenticated-orcid":false,"given":"Vitor","family":"Coutinho Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-5134","authenticated-orcid":false,"given":"Manuel","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-8982","authenticated-orcid":false,"given":"Malin","family":"Nientiedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice Stephan","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5471-4277","authenticated-orcid":false,"given":"Manuel","family":"Rodriguez-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-5431","authenticated-orcid":false,"given":"Frank","family":"Lyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"739_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/diagnostics10010039","volume":"10","author":"R Batista","year":"2020","unstructured":"Batista R, Vinagre N, Meireles S, Vinagre J, Prazeres H, Le\u00e3o R, M\u00e1ximo V, Soares P (2020) Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review. Diagnostics 10:39","journal-title":"Diagnostics"},{"key":"739_CR2","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","volume":"551","author":"C Berdik","year":"2017","unstructured":"Berdik C (2017) Unlocking bladder cancer. Nature 551:S34\u2013s35","journal-title":"Nature"},{"key":"739_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40291-023-00647-0","volume":"27","author":"M Bou Zerdan","year":"2023","unstructured":"Bou Zerdan M, Bratslavsky G, Jacob J, Ross J, Huang R, Basnet A (2023) Urothelial bladder cancer: genomic alterations in fibroblast growth factor receptor. Mol Diagn Ther 27:475\u2013485","journal-title":"Mol Diagn Ther"},{"key":"739_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41576-022-00534-0","volume":"24","author":"K Boulias","year":"2023","unstructured":"Boulias K, Greer EL (2023) Biological roles of adenine methylation in RNA. Nat Rev Genet 24:143\u2013160","journal-title":"Nat Rev Genet"},{"key":"739_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41420-021-00703-w","volume":"7","author":"X Cai","year":"2021","unstructured":"Cai X, Chen Y, Man D, Yang B, Feng X, Zhang D, Chen J, Wu J (2021) RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner. Cell Death Discov 7:315","journal-title":"Cell Death Discov"},{"key":"739_CR6","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","volume":"38","author":"M Cheng","year":"2019","unstructured":"Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, Liang Y, Zhu F, Zhang Y, Zhang X et al (2019) The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network. Oncogene 38:3667\u20133680","journal-title":"Oncogene"},{"key":"739_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01510-2","volume":"21","author":"L-J Deng","year":"2022","unstructured":"Deng L-J, Deng W-Q, Fan S-R, Chen M-F, Qi M, Lyu W-Y, Qi Q, Tiwari AK, Chen J-X, Zhang D-M et al (2022) m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer 21:52","journal-title":"Mol Cancer"},{"key":"739_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, Huang H, Chen J (2023) The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol 20:507\u2013526","journal-title":"Nat Rev Clin Oncol"},{"key":"739_CR9","doi-asserted-by":"crossref","unstructured":"Destefanis E, Sighel D, Dalfovo D, Gilmozzi R, Broso F, Cappannini A, Bujnicki JM, Romanel A, Dassi E, Quattrone A (2024) The three YTHDF paralogs and VIRMA are the major tumor drivers among the m6A core genes in a pan-cancer analysis. NAR Cancer 6(4):zcae040","DOI":"10.1093\/narcan\/zcae040"},{"key":"739_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41592-021-01242-z","volume":"18","author":"D Dierks","year":"2021","unstructured":"Dierks D, Garcia-Campos MA, Uzonyi A, Safra M, Edelheit S, Rossi A, Sideri T, Varier RA, Brandis A, Stelzer Y et al (2021) Multiplexed profiling facilitates robust m6A quantification at site, gene and sample resolution. Nat Methods 18:1060\u20131067","journal-title":"Nat Methods"},{"key":"739_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"739_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M et al (2012) Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485:201\u2013206","journal-title":"Nature"},{"key":"739_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D (2023) Bladder cancer. Nat Rev Dis Prim 9:58","journal-title":"Nat Rev Dis Prim"},{"key":"739_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-052521-035330","volume":"92","author":"MN Flamand","year":"2023","unstructured":"Flamand MN, Tegowski M, Meyer KD (2023) The proteins of mRNA modification: writers, readers, and erasers. Annu Rev Biochem 92:145\u2013173","journal-title":"Annu Rev Biochem"},{"key":"739_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.eururo.2011.05.035","volume":"60","author":"A Fleischmann","year":"2011","unstructured":"Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN (2011) Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol 60:350\u2013357","journal-title":"Eur Urol"},{"key":"739_CR16","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R (2020) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36:2628\u20132629","journal-title":"Bioinformatics"},{"key":"739_CR17","doi-asserted-by":"crossref","unstructured":"Gill E, Perks CM (2024) Mini-Review: Current bladder cancer treatment-the need for improvement. Int J Mol Sci 25:1557","DOI":"10.3390\/ijms25031557"},{"key":"739_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41585-018-0005-1","volume":"15","author":"A Goriki","year":"2018","unstructured":"Goriki A, Seiler R, Wyatt AW, Contreras-Sanz A, Bhat A, Matsubara A, Hayashi T, Black PC (2018) Unravelling disparate roles of NOTCH in bladder cancer. Nat Rev Urol 15:345\u2013357","journal-title":"Nat Rev Urol"},{"key":"739_CR19","doi-asserted-by":"publisher","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","volume":"9","author":"C Guzm\u00e1n","year":"2014","unstructured":"Guzm\u00e1n C, Bagga M, Kaur A, Westermarck J, Abankwa D (2014) ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS ONE 9:e92444","journal-title":"PLoS ONE"},{"key":"739_CR20","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C (2021) m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J 40:e105977","journal-title":"EMBO J"},{"key":"739_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576\u2013589","journal-title":"Mol Cell"},{"key":"739_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13684-3","volume":"10","author":"M Helm","year":"2019","unstructured":"Helm M, Lyko F, Motorin Y (2019) Limited antibody specificity compromises epitranscriptomic analyses. Nat Commun 10:5669","journal-title":"Nat Commun"},{"key":"739_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","volume":"22","author":"T Helsten","year":"2016","unstructured":"Helsten T, Elkin S, Arthur E, Tomson BN, Carter J, Kurzrock R (2016) The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing. Clin Cancer Res 22:259\u2013267","journal-title":"Clin Cancer Res"},{"key":"739_CR24","doi-asserted-by":"publisher","first-page":"gkaf1314","DOI":"10.1093\/nar\/gkaf1314","volume":"53","author":"C Hewel","year":"2025","unstructured":"Hewel C, Wierczeiko A, Miedema J, Friedrich J, Hofmann F, Wei\u00dfbach S, Dietrich V, Holth\u00f6fer L, Haug V, M\u00fcndnich S et al (2025) Direct RNA sequencing enables improved transcriptome assessment and tracking of RNA modifications for medical applications. Nucleic Acids Res 53:gkaf1314","journal-title":"Nucleic Acids Res"},{"key":"739_CR25","doi-asserted-by":"publisher","first-page":"107464","DOI":"10.1016\/j.celrep.2020.03.028","volume":"31","author":"M Hirayama","year":"2020","unstructured":"Hirayama M, Wei FY, Chujo T, Oki S, Yakita M, Kobayashi D, Araki N, Takahashi N, Yoshida R, Nakayama H et al (2020) FTO demethylates Cyclin D1 mRNA and controls cell-cycle progression. Cell Rep 31:107464","journal-title":"Cell Rep"},{"key":"739_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ebiom.2019.07.068","volume":"47","author":"H Jin","year":"2019","unstructured":"Jin H, Ying X, Que B, Wang X, Chao Y, Zhang H, Yuan Z, Qi D, Lin S, Min W et al (2019) N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine 47:195\u2013207","journal-title":"EBioMedicine"},{"key":"739_CR27","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1101\/gad.269415.115","volume":"29","author":"S Ke","year":"2015","unstructured":"Ke S, Alemu EA, Mertens C, Gantman EC, Fak JJ, Mele A, Haripal B, Zucker-Scharff I, Moore MJ, Park CY et al (2015) A majority of m6A residues are in the last exons, allowing the potential for 3\u2019 UTR regulation. Genes Dev 29:2037\u20132053","journal-title":"Genes Dev"},{"key":"739_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37:907\u2013915","journal-title":"Nat Biotechnol"},{"key":"739_CR29","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1093\/ajcp\/aqad150.202","volume":"160","author":"M Kluth","year":"2023","unstructured":"Kluth M, Hitzschke M, Lennartz M, Blessin NC, Sauter G, Plage H, Klatte T, Schlomm T, Marx AH, Rink M et al (2023) MYC amplifications are a common event in urothelial bladder carcinomas associated with an aggressive tumor phenotype. Am J Clin Pathol 160:S91\u2013S92","journal-title":"Am J Clin Pathol"},{"key":"739_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD (2015) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 15:25\u201341","journal-title":"Nat Rev Cancer"},{"key":"739_CR31","doi-asserted-by":"publisher","first-page":"102242","DOI":"10.1016\/j.gde.2024.102242","volume":"88","author":"J Koch","year":"2024","unstructured":"Koch J, Lyko F (2024) Refining the role of N6-methyladenosine in cancer. Curr Opin Genet Dev 88:102242","journal-title":"Curr Opin Genet Dev"},{"key":"739_CR32","doi-asserted-by":"publisher","first-page":"107300","DOI":"10.1016\/j.isci.2023.107300","volume":"26","author":"J Koch","year":"2023","unstructured":"Koch J, Neuberger M, Schmidt-Dengler M, Xu J, Carneiro VC, Ellinger J, Kriegmair MC, Nuhn P, Erben P, Michel MS et al (2023) Reinvestigating the clinical relevance of the m(6)A writer METTL3 in urothelial carcinoma of the bladder. iScience 26:107300","journal-title":"iScience"},{"key":"739_CR33","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, Liu PY, Haase J, Bell JL, H\u00fcttelmaier S, Liu T (2019) The critical role of RNA m(6)A methylation in cancer. Cancer Res 79:1285\u20131292","journal-title":"Cancer Res"},{"key":"739_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25","journal-title":"Genome Biol"},{"key":"739_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00018-023-04799-4","volume":"80","author":"Q Lee","year":"2023","unstructured":"Lee Q, Song R, Phan DAV, Pinello N, Tieng J, Su A, Halstead JM, Wong ACH, van Geldermalsen M, Lee BS et al (2023) Overexpression of VIRMA confers vulnerability to breast cancers via the m(6)A-dependent regulation of unfolded protein response. Cell Mol Life Sci 80:157","journal-title":"Cell Mol Life Sci"},{"key":"739_CR36","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R (2009) The sequence alignment\/Map format and SAMtools. Bioinformatics 25:2078\u20132079","journal-title":"Bioinformatics"},{"key":"739_CR37","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/mc.23680","volume":"63","author":"H Li","year":"2024","unstructured":"Li H, Li C, Zhang Y, Jiang W, Zhang F, Tang X, Sun G, Xu S, Dong X, Shou J et al (2024) Comprehensive analysis of m(6) A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma. Mol Carcinog 63:677\u2013687","journal-title":"Mol Carcinog"},{"key":"739_CR38","doi-asserted-by":"publisher","first-page":"e55506","DOI":"10.15252\/embr.202255506","volume":"24","author":"N Li","year":"2023","unstructured":"Li N, Zhu Z, Deng Y, Tang R, Hui H, Kang Y, Rana TM (2023) KIAA1429\/VIRMA promotes breast cancer progression by m(6) A-dependent cytosolic HAS2 stabilization. EMBO Rep 24:e55506","journal-title":"EMBO Rep"},{"key":"739_CR39","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W (2013) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923\u2013930","journal-title":"Bioinformatics"},{"key":"739_CR40","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SR (2015) Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods 12:767\u2013772","journal-title":"Nat Methods"},{"key":"739_CR41","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1101\/gr.083451.108","volume":"19","author":"R Lister","year":"2009","unstructured":"Lister R, Ecker JR (2009) Finding the fifth base: genome-wide sequencing of cytosine methylation. Genome Res 19:959\u2013966","journal-title":"Genome Res"},{"key":"739_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41587-022-01487-9","volume":"41","author":"C Liu","year":"2023","unstructured":"Liu C, Sun H, Yi Y, Shen W, Li K, Xiao Y, Li F, Li Y, Hou Y, Lu B et al (2023) Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat Biotechnol 41:355\u2013366","journal-title":"Nat Biotechnol"},{"key":"739_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.molcel.2019.09.032","volume":"77","author":"J Liu","year":"2020","unstructured":"Liu J, Li K, Cai J, Zhang M, Zhang X, Xiong X, Meng H, Xu X, Huang Z, Peng J et al (2020) Landscape and Regulation of m(6)A and m(6)Am Methylome across Human and Mouse Tissues. Mol Cell 77:426\u2013440.e426","journal-title":"Mol Cell"},{"key":"739_CR44","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L (2024) Advances in diagnosis and treatment of bladder cancer. BMJ 384:e076743","journal-title":"BMJ"},{"key":"739_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"739_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3892\/ijo.2014.2765","volume":"46","author":"B Mao","year":"2015","unstructured":"Mao B, Zhang Z, Wang G (2015) BTG2: a rising star of tumor suppressors (review). Int J Oncol 46:459\u2013464","journal-title":"Int J Oncol"},{"key":"739_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63355-3","volume":"10","author":"ABR McIntyre","year":"2020","unstructured":"McIntyre ABR, Gokhale NS, Cerchietti L, Jaffrey SR, Horner SM, Mason CE (2020) Limits in the detection of m6A changes using MeRIP\/m6A-seq. Sci Rep 10:6590","journal-title":"Sci Rep"},{"key":"739_CR48","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR (2012) Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell 149:1635\u20131646","journal-title":"Cell"},{"key":"739_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1615\/CritRevEukarGeneExpr.v17.i4.30","volume":"17","author":"C Millet","year":"2007","unstructured":"Millet C, Zhang YE (2007) Roles of Smad3 in TGF-beta signaling during carcinogenesis. Crit Rev Eukaryot Gene Expr 17:281\u2013293","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"739_CR50","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nmeth.3898","volume":"13","author":"B Molinie","year":"2016","unstructured":"Molinie B, Wang J, Lim KS, Hillebrand R, Lu ZX, Van Wittenberghe N, Howard BD, Daneshvar K, Mullen AC, Dedon P et al (2016) m(6)A-LAIC-seq reveals the census and complexity of the m(6)A epitranscriptome. Nat Methods 13:692\u2013698","journal-title":"Nat Methods"},{"key":"739_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0767-x","volume":"16","author":"M Nettling","year":"2015","unstructured":"Nettling M, Treutler H, Grau J, Keilwagen J, Posch S, Grosse I (2015) DiffLogo: a comparative visualization of sequence motifs. BMC Bioinforma 16:387","journal-title":"BMC Bioinforma"},{"key":"739_CR52","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/bioinformatics\/btu339","volume":"30","author":"Y Park","year":"2014","unstructured":"Park Y, Figueroa ME, Rozek LS, Sartor MA (2014) MethylSig: a whole genome DNA methylation analysis pipeline. Bioinformatics 30:2414\u20132422","journal-title":"Bioinformatics"},{"key":"739_CR53","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841\u2013842","journal-title":"Bioinformatics"},{"key":"739_CR54","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney L (2020) The global burden of urinary bladder cancer: an update. World J Urol 38:1895\u20131904","journal-title":"World J Urol"},{"key":"739_CR55","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41594-023-01089-2","volume":"30","author":"RJ Ries","year":"2023","unstructured":"Ries RJ, Pickering BF, Poh HX, Namkoong S, Jaffrey SR (2023) m(6)A governs length-dependent enrichment of mRNAs in stress granules. Nat Struct Mol Biol 30:1525\u20131535","journal-title":"Nat Struct Mol Biol"},{"key":"739_CR56","doi-asserted-by":"crossref","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A (2020) Epidemiology of bladder cancer. Med Sci 8:15","DOI":"10.3390\/medsci8010015"},{"key":"739_CR57","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.7150\/jca.60381","volume":"13","author":"L Sang","year":"2022","unstructured":"Sang L, Wu X, Yan T, Naren D, Liu X, Zheng X, Zhang N, Wang H, Li Y, Gong Y (2022) The m(6)A RNA methyltransferase METTL3\/METTL14 promotes leukemogenesis through the mdm2\/p53 pathway in acute myeloid leukemia. J Cancer 13:1019\u20131030","journal-title":"J Cancer"},{"key":"739_CR58","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.celrep.2014.05.048","volume":"8","author":"S Schwartz","year":"2014","unstructured":"Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N, Cacchiarelli D et al (2014) Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5\u2019 sites. Cell Rep 8:284\u2013296","journal-title":"Cell Rep"},{"key":"739_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03182-1","volume":"25","author":"R Shachar","year":"2024","unstructured":"Shachar R, Dierks D, Garcia-Campos MA, Uzonyi A, Toth U, Rossmanith W, Schwartz S (2024) Dissecting the sequence and structural determinants guiding m6A deposition and evolution via inter- and intra-species hybrids. Genome Biol 25:48","journal-title":"Genome Biol"},{"key":"739_CR60","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41596-023-00937-1","volume":"19","author":"W Shen","year":"2024","unstructured":"Shen W, Sun H, Liu C, Yi Y, Hou Y, Xiao Y, Hu Y, Lu B, Peng J, Wang J et al (2024) GLORI for absolute quantification of transcriptome-wide m6A at single-base resolution. Nat Protoc 19:1252\u20131287","journal-title":"Nat Protoc"},{"key":"739_CR61","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349","journal-title":"CA Cancer J Clin"},{"key":"739_CR62","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.3029","volume":"11","author":"NA Siegfried","year":"2014","unstructured":"Siegfried NA, Busan S, Rice GM, Nelson JAE, Weeks KM (2014) RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP). Nat Methods 11:959\u2013965","journal-title":"Nat Methods"},{"key":"739_CR63","doi-asserted-by":"publisher","first-page":"93279","DOI":"10.18632\/oncotarget.21565","volume":"8","author":"X Sui","year":"2017","unstructured":"Sui X, Lei L, Chen L, Xie T, Li X (2017) Inflammatory microenvironment in the initiation and progression of bladder cancer. Oncotarget 8:93279\u201393294","journal-title":"Oncotarget"},{"key":"739_CR64","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013465","journal-title":"Eur Urol"},{"key":"739_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm.2016.116","volume":"18","author":"B Tian","year":"2017","unstructured":"Tian B, Manley JL (2017) Alternative polyadenylation of mRNA precursors. Nat Rev Mol Cell Biol 18:18\u201330","journal-title":"Nat Rev Mol Cell Biol"},{"key":"739_CR66","doi-asserted-by":"publisher","first-page":"216122","DOI":"10.1016\/j.canlet.2023.216122","volume":"559","author":"L Wang","year":"2023","unstructured":"Wang L, Yang Q, Zhou Q, Fang F, Lei K, Liu Z, Zheng G, Zhu L, Huo J, Li X et al (2023) METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma. Cancer Lett 559:216122","journal-title":"Cancer Lett"},{"key":"739_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6274","volume":"5","author":"Z Xia","year":"2014","unstructured":"Xia Z, Donehower LA, Cooper TA, Neilson JR, Wheeler DA, Wagner EJ, Li W (2014) Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3\u2019-UTR landscape across seven tumour types. Nat Commun 5:5274","journal-title":"Nat Commun"},{"key":"739_CR68","doi-asserted-by":"publisher","first-page":"216840","DOI":"10.1016\/j.canlet.2024.216840","volume":"590","author":"K Yang","year":"2024","unstructured":"Yang K, Zhong Z, Zou J, Liao JY, Chen S, Zhou S, Zhao Y, Li J, Yin D, Huang K et al (2024a) Glycolysis and tumor progression promoted by the m(6)A writer VIRMA via m(6)A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma. Cancer Lett 590:216840","journal-title":"Cancer Lett"},{"key":"739_CR69","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41585-023-00851-x","volume":"21","author":"L Yang","year":"2024","unstructured":"Yang L, Ying J, Tao Q, Zhang Q (2024b) RNA N(6)-methyladenosine modifications in urological cancers: from mechanism to application. Nat Rev Urol 21:460\u2013476","journal-title":"Nat Rev Urol"},{"key":"739_CR70","doi-asserted-by":"publisher","first-page":"e0234696","DOI":"10.1371\/journal.pone.0234696","volume":"15","author":"F Yu","year":"2020","unstructured":"Yu F, Zhang Y, Cheng C, Wang W, Zhou Z, Rang W, Yu H, Wei Y, Wu Q, Zhang Y (2020) Poly(A)-seq: a method for direct sequencing and analysis of the transcriptomic poly(A)-tails. PLoS ONE 15:e0234696","journal-title":"PLoS ONE"},{"key":"739_CR71","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gendis.2019.10.011","volume":"8","author":"F Yuan","year":"2021","unstructured":"Yuan F, Hankey W, Wagner EJ, Li W, Wang Q (2021) Alternative polyadenylation of mRNA and its role in cancer. Genes Dis 8:61\u201372","journal-title":"Genes Dis"},{"key":"739_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","volume":"4","author":"Y Yue","year":"2018","unstructured":"Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang Z, Cheng T, Gao M, Shu X, Ma H et al (2018) VIRMA mediates preferential m(6)A mRNA methylation in 3\u2019UTR and near stop codon and associates with alternative polyadenylation. Cell Discov 4:10","journal-title":"Cell Discov"},{"key":"739_CR73","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1002\/jcp.27407","volume":"234","author":"L Yuniati","year":"2019","unstructured":"Yuniati L, Scheijen B, van der Meer LT, van Leeuwen FN (2019) Tumor suppressors BTG1 and BTG2: beyond growth control. J Cell Physiol 234:5379\u20135389","journal-title":"J Cell Physiol"},{"key":"739_CR74","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20:608\u2013624","journal-title":"Nat Rev Mol Cell Biol"},{"key":"739_CR75","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ijc.21253","volume":"117","author":"B Zaharieva","year":"2005","unstructured":"Zaharieva B, Simon R, Ruiz C, Oeggerli M, Mihatsch MJ, Gasser T, Sauter G, Toncheva D (2005) High-throughput tissue microarray analysis of CMYC amplification in urinary bladder cancer. Int J Cancer 117:952\u2013956","journal-title":"Int J Cancer"},{"key":"739_CR76","doi-asserted-by":"crossref","unstructured":"Zhang C, Scott RL, Tunes L, Hsieh MH, Wang P, Kumar A, Khadgi BB, Yang YY, Doxtader Lacy KA, Herrell E et al (2023) Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14. Sci Adv 10(51):eads4750","DOI":"10.1126\/sciadv.ads4750"},{"key":"739_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05701-x","volume":"22","author":"L Zhang","year":"2024","unstructured":"Zhang L, Chen Z, Sun G, Li C, Wu P, Xu W, Zhu H, Zhang Z, Tang Y, Li Y et al (2024) Dynamic landscape of m6A modifications and related post-transcriptional events in muscle-invasive bladder cancer. J Transl Med 22:912","journal-title":"J Transl Med"},{"key":"739_CR78","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41392-023-01428-1","volume":"8","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Li Y, Zhu R, Feng R, Cui H, Yu X, Huang F, Zhang R, Chen X, Li L et al (2023) RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m(6)A modification. Signal Transduct Target Ther 8:224","journal-title":"Signal Transduct Target Ther"},{"key":"739_CR79","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1261\/rna.057075.116","volume":"22","author":"D Zheng","year":"2016","unstructured":"Zheng D, Liu X, Tian B (2016) 3\u2019READS+, a sensitive and accurate method for 3\u2019 end sequencing of polyadenylated RNA. RNA 22:1631\u20131639","journal-title":"RNA"},{"key":"739_CR80","doi-asserted-by":"publisher","first-page":"104677","DOI":"10.1016\/j.jbc.2023.104677","volume":"299","author":"ZQ Zheng","year":"2023","unstructured":"Zheng ZQ, Huang ZH, Liang YL, Zheng WH, Xu C, Li ZX, Liu N, Yang PY, Li YQ, Ma J et al (2023) VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. J Biol Chem 299:104677","journal-title":"J Biol Chem"},{"key":"739_CR81","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.17305\/bb.2024.10358","volume":"24","author":"C Zhu","year":"2024","unstructured":"Zhu C, Cheng Y, Yu Y, Zhang Y, Ren G (2024) VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels. Biomol Biomed 24:1244\u20131257","journal-title":"Biomol Biomed"},{"key":"739_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01868-1","volume":"21","author":"W Zhu","year":"2021","unstructured":"Zhu W, Wang JZ, Wei JF, Lu C (2021) Role of m6A methyltransferase component VIRMA in multiple human cancers (Review). Cancer Cell Int 21:172","journal-title":"Cancer Cell Int"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-026-00739-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:35:55Z","timestamp":1779122155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-026-00739-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":82,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4,27]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1038\/s44319-026-00739-y","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}